ECOG - S0438 - Randomized Phase II Trial of Bay 43-9006 ( Sorafenib; NSC-724772) with Either CCI-779 ( Temsirolimus; NSC-683864) or R115777 ( Tipifarnib; NSC-70218) in Metastatic Melanoma.

Clinical Trial Categories

• Melanoma

Contact

The Rosenfeld Cancer Center at 215-481-2402